As shown in Figure 6, the expression of CDKN1A was equally upregulated in a dose-dependent manner in both cancer cell lines and increased threefold (RK33 *** p < 0.001; TE671 **** p < 0.0001) versus the control in the presence of 100μM IMP. Here, CDKN1A is linked to cancer.